๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix

โœ Scribed by Claire F. Verschraegen; John J. Kavanagh; Evelyne Loyer; Diane Bodurka-Bevers; Andrzej P. Kudelka; Wei Hu; Monique Vincent; Tarra Nelson; Charles Levenback; Community Clinical Oncology Program


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
85 KB
Volume
92
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


BACKGROUND.

The activity of the combination of carboplatin and liposomal doxorubicin was tested in a Phase II study of patients with recurrent cervical carcinoma.

METHODS. The combination of carboplatin (area under the concentration curve

[AUC], 5) and liposomal doxorubicin (Doxil; starting dose, 40 mg/m 2 ) was administered intravenously every 28 days to 37 patients with recurrent squamous cell cervical carcinoma to determine antitumor activity and toxicity profile.


๐Ÿ“œ SIMILAR VOLUMES